Cell Therapy Manufacturing & Gene Therapy Congress is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Ohad Karnieli, Ph.D., MBA
Founder and CEO at ADVA Biotechnology

Profile

A well-known international expert in cell therapy with extensive knowledge of the industry. Dr Karnieli is the founder and President of Atvio Biotech, a leading Innovation center for cell and gene therapy. Former VP of Technology & Manufacturing at Pluristem Therapeutics, and the former VP medical device at Goji solutions. Dr Karnieli served as the chair of several industry committees such as the process & product development committee of the International Society for Cellular Therapies, expert member in the ISO TC276 Biotechnology standard committee and the former chair of the science and technology committee of the Alliance for Regenerative Medicine. Furthermore, Dr Karnieli serves as an advisor and board member to several of the lead cell therapy developing companies. Dr Karnieli earned his PhD on Cell and Gene Therapy in the Sackler School of Medicine of the Tel Aviv University. Furthermore, he holds an MBA from the Haifa University business management school.

Ohad Karnieli, Ph.D., MBA's Network

Agenda Sessions

  • Chairperson’s Opening Remarks

    , 11:10
  • Partnership and collaboration: Can more collaboration solve a multitude of problems?

    , 14:05
  • CMO landscapes for new product initiatives: Novel outsourcing models

    , 15:00

Speakers at this event